We are international
Donate
• about myeloma TEXT SIZE   
publications    back

Myeloma Minute
August 28, 2014
08.28.14
August 28, 2014
Share the Minute Facebook Tweet!
Clinical 
Trials
Donate to the IMF
x

IMF to Host Congressional Briefing on Myeloma and Environmental Exposures

The IMF will host a congressional briefing, “Understanding Environmental Exposures and Cancer: The Case of Multiple Myeloma,” on September 10th in Washington, DC. The briefing will highlight research on certain groups of people who have an increased risk of developing myeloma, specifically those present at the 9/11 sites and agriculturalists. Congress members and their staff will learn about multiple myeloma and opportunities to further research potential environmental risk factors for myeloma. READ MORE



This week's question: Is there a test to measure Minimal Residual Disease (MRD)?


Upcoming Events


Saturday, September 6, 2014
2nd Annual Wine Tasting and Tour of White Hall Vineyards, Veritas Vineyards, and Delfosse Vineyard and Winery
Richmond, Virginia

Saturday, September 27, 2014
Regional Community Workshop
Houston, Texas
Saturday, November 8, 2014
Save the Date!

8th Annual Comedy Celebration
Los Angeles, California


Shop at the IMF Mall & Support the IMF

 

 

 

x

Research on New Approach to Detect Bone Loss in Myeloma

Researchers from Arizona State University and the Mayo Clinic recently published a study in the journal Leukemia on a blood test for calcium atoms that could be used in the future to monitor bone loss associated with myeloma. The method is commonly used in earth science and detects calcium atoms with different masses. Study author and Arizona State University professor Ariel Anbar, PhD, explained, “If the method proves to be robust after more careful validation, it could provide earlier detection of bone involvement than presently possible.” READ MORE
x

Quality of Life Assessments in Myeloma Care

A study recently published in BioMed Central Cancer examined how quality of life (QOL) issues are assessed by myeloma patients and their healthcare providers. Study authors spoke to myeloma patients to find which QOL issues are most important to them and get feedback on existing QOL questionnaires. The authors concluded that QOL assessments need improvement and suggest, “Questionnaires for use in the clinical care of myeloma patients should capture the impact of symptoms on activity, participation or emotional status, and avoid simply asking about symptom status.” READ MORE

 
x

Attend the IMF’s Regional Community Workshop in Wheeling, Illinois

The IMF’s next Regional Community Workshop is right around the corner on Saturday, September 6th in Wheeling, Illinois. Led by Jonathan Kaufman, MD, from the Winship Cancer Institute, Craig Hofmeister, MD, from Ohio State University, and IMF Nurse Leadership Board member Joseph Tariman, PhD, ANP-BC, this free half-day workshop at the Westin Chicago North Shore will include presentations on the latest developments in myeloma research and treatment, and will provide opportunities for invaluable patient-doctor interactions. CLICK HERE to register.

 

Join Our Mailing List

 

 

 

 

12650 Riverside Drive, Suite 206 | North Hollywood, CA 91607-3421
IMF Hotline: 800-452-2873 or 818-487-7455
Privacy Policy | Unsubscribe
www.myeloma.org

 related articles